the future of money digital currency

Trump said that he chose Andrew Feargus, Commissioner of the US Federal Trade Commission (FTC), as the FTC chairman.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.The second meeting of the Global Foreign Exchange Market Committee in 2024 was successfully held. From December 5 to December 6, 2024, the second meeting of the Global Foreign Exchange Committee (GFXC) in 2024 was held online. The meeting discussed the promotion and implementation of global standards, the second round of three-year review of global standards, the operation of foreign exchange market and related market hot issues. Representatives from China Foreign Exchange Market Steering Committee (CFXC) attended the meeting. This meeting discussed the final results of the second round of three-year review of global standards. The Working Group on Foreign Exchange Settlement Risk and the Working Group on Foreign Exchange Data respectively introduced the final revision suggestions of the relevant provisions of the global standards, and how the Working Group continuously improved according to the public comments and feedback from the local foreign exchange market committees and in October 2024. The revision of the Global Standards aims to strengthen the relevant principles of foreign exchange settlement risk management and enhance the transparency of specific types of foreign exchange transactions and the use of customer-generated data on electronic trading platforms. GFXC members strongly support this.

Xie Yunliang, macro chief analyst of Cinda Securities, said that historically, the establishment of a "moderately loose" policy orientation needs to meet two major conditions, namely, the domestic pressure to stabilize prices is high and the foreign Federal Reserve is in a loose cycle. At present, it is judged that both situations may exist next year.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Sarah Friar, CFO of OpenAI: Corporate customers will pay (at least) thousands of dollars for using artificial intelligence (AI) tools. In the end, it will be reasonable.

Yuanyuan Communication: The plan being evaluated and negotiated between the company and toy manufacturers does not involve ByteDance, and the results of subsequent negotiations are still uncertain.Ukrainian industrial sources: The attack on an oil depot in the Bryansk region of Russia did not affect the oil transportation to Europe via Ukraine.One case of pre-application for residential land in Fengtai District, Beijing, with an initial total price of 4.008 billion yuan. According to official website of Beijing Municipal Planning and Natural Resources Committee, one case of pre-application for residential land in Fengtai District, Beijing, with an initial total price of 4.008 billion yuan. This plot is plot No.056 [2024], namely plot FT00-2404-0005 of the reconstruction project of the cold storage in the southwest suburb of Fengtai District, Beijing, with a land area of 27,422.21 square meters and a planned construction area of 69,104 square meters. The pre-application for this plot will be accepted from December 9, 2024 to January 7, 2025.